Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: A retrospective study.

This study aimed to assess the outcome and factors associated with mortality in patients who received urgent chemotherapy (CT) in the intensive care unit (ICU) in Lyon, France. A total of 147 adult patients diagnosed with cancer and requiring urgent CT during ICU stay between October 2014 and December 2019 were included in this retrospective study. Hematological cancer was found in 77% of patients, and acute respiratory failure was the leading cause of ICU admission (46.3%). The 6-month mortality rate was 69.4%; patients with solid cancer had a higher risk of mortality. Patients who died within 6 months had a poor performance score and a higher SOFA score at admission. The multivariate analysis showed that solid tumors, sepsis on the day of CT, and SOFA score on the day of CT were associated with 6-month mortality. Additionally, 95% of patients who survived the ICU resumed conventional CT, with a higher likelihood of resuming CT among those with hematological cancer. Urgent CT in the ICU is feasible in a specific subset of patients, mainly those with hematological cancer, with resumption of the curative treatment regimen after ICU discharge.

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest J. BERNARD has no conflict of interest. C.H. VACHERON has no conflict of interest. N. VANTARD has no conflict of interest. E. BACHY has no conflict of interest. J.C. RICHARD has no conflict of interest. F. AUBRUN has no conflict of interest. M. COUR has no conflict of interest. AC. LUKASZEWICZ has no conflict of interest. J. BOHE has no conflict of interest. B. ALLAOUCHICHE has no conflict of interest. A. FRIGGERI has no conflict of interest. F. WALLET has no conflict of interest.